{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:22:28Z","timestamp":1795101748971,"version":"4.10.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.parkreldis.2023.105405","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T21:31:53Z","timestamp":1682717513000},"page":"105405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["GNAO1-related movement disorder: An update on phenomenology, clinical course, and response to treatments"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4451-3388","authenticated-orcid":false,"given":"Maria","family":"Novelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Galosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Nardecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Di Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Efisio","family":"Marras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardo","family":"Nardocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2023.105405_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.886751","article-title":"Motor, epileptic, and developmental phenotypes in genetic disorders affecting G protein coupled receptors-cAMP signaling","volume":"13","author":"Galosi","year":"2022","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2023.105405_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors","volume":"3","author":"Pierce","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105405_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygeno.2006.04.001","article-title":"Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse","volume":"88","author":"Bjarnad\u00f3ttir","year":"2006","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105405_bib4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10545-018-0205-0","article-title":"Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms","volume":"41","author":"Abela","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"35","key":"10.1016\/j.parkreldis.2023.105405_bib5","doi-asserted-by":"crossref","first-page":"23846","DOI":"10.18632\/oncotarget.22067","article-title":"G\u03b1o (GNAO1) encephalopathies: plasma membrane vs. Golgi functions","volume":"9","author":"Solis","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105405_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108718","article-title":"G\u03b1o is a major determinant of cAMP signaling in the pathophysiology of movement disorders","volume":"34","author":"Muntean","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105405_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/jnnp-2017-315653","article-title":"GNAO1-related movement disorder with life-threatening exacerbations: movement phenomenology and response to DBS","volume":"89","author":"Waak","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105405_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajhg.2013.07.014","article-title":"De Novo mutations in GNAO1, encoding a G\u03b1o subunit of heterotrimeric G proteins, cause epileptic encephalopathy","volume":"93","author":"Nakamura","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105405_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ejhg.2015.92","article-title":"Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay","volume":"24","author":"Saitsu","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105405_bib10","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000143","article-title":"GNAO1 encephalopathy: broadening the phenotype and evaluating treatment and outcome","volume":"3","author":"Danti","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.parkreldis.2023.105405_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.parkreldis.2018.11.019","article-title":"Phenomenology and clinical course of movement disorder in GNAO1 variants: results from an analytical review","volume":"61","author":"Schirinzi","year":"2019","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105405_bib12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00702-019-02010-2","article-title":"Long-term effect of subthalamic and pallidal deep brain stimulation for status dystonicus in children with methylmalonic acidemia and GNAO1 mutation","volume":"126","author":"Benato","year":"2019","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2023.105405_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pediatrneurol.2016.02.018","article-title":"Clinical course of six children with GNAO1 mutations causing a severe and distinctive movement disorder","volume":"59","author":"Ananth","year":"2016","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105405_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/epi.14653","article-title":"Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region","volume":"60","author":"Kelly","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2023.105405_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2019.106181","article-title":"Genetic heterogeneity in infantile spasms","volume":"156","author":"Muir","year":"2019","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.parkreldis.2023.105405_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2021.05.020","article-title":"Severe bradyarrhythmia during adrenocorticotropic hormone treatment of infantile spasms","volume":"122","author":"Xie","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105405_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221093507","article-title":"Both subthalamic and pallidal deep brain stimulation are effective for GNAO1-associated dystonia: three case reports and a literature review","volume":"15","author":"Liu","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105405_bib18","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mds.29074","article-title":"Highlighting the dystonic phenotype related to GNAO1","volume":"37","author":"Wirth","year":"2022","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105405_bib19","doi-asserted-by":"crossref","DOI":"10.17724\/jicna.2020.168","article-title":"Expanding the phenotype of GNAO1 related movement disorders: two cases with mild phenotypes","volume":"1","author":"Abu Libdeh","year":"2020","journal-title":"Journal of the International Child Neurology Association"},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105405_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13023-020-01594-3","article-title":"Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis","volume":"15","author":"Kim","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.parkreldis.2023.105405_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2018.05.018","article-title":"Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia","volume":"391","author":"Koy","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105405_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mdc3.13118","article-title":"Brittle biballism-dystonia in a pediatric patient with GNAO1 mutation managed using pallidal deep brain stimulation","volume":"8","author":"Danhofer","year":"2021","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105405_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mds.27291","article-title":"Rethinking status dystonicus: a welcome start to a challenging problem","volume":"33","author":"Lumsden","year":"2018","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105405_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dmcn.12339","article-title":"Status dystonicus: a practice guide","volume":"56","author":"Allen","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105405_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0038-1645884","article-title":"Multiple causes of pediatric early onset chorea-clinical and genetic approach","volume":"49","author":"Blumkin","year":"2018","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.parkreldis.2023.105405_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.04.003","article-title":"Increased diagnostic yield in complex dystonia through exome sequencing","volume":"74","author":"Wirth","year":"2020","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105405_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0037-1603977","article-title":"Expanding phenotype of de novo mutations in GNAO1: four new cases and review of literature","volume":"48","author":"Schorling","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.parkreldis.2023.105405_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nbd.2018.05.005","article-title":"A mechanistic review on GNAO1-associated movement disorder","volume":"116","author":"Feng","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.parkreldis.2023.105405_bib29","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.molcel.2021.02.002","article-title":"A universal allosteric mechanism for G protein activation","volume":"81","author":"Knight","year":"2021","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105405_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10048-022-00686-5","article-title":"An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation","volume":"23","author":"Miyamoto","year":"2022","journal-title":"Neurogenetics"},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105405_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mdc3.12344","article-title":"GNAO1-Associated movement disorder","volume":"3","author":"Dhamija","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105405_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.braindev.2020.12.002","article-title":"GNAO1 mutation-related severe involuntary movements treated with gabapentin","volume":"43","author":"Akasaka","year":"2021","journal-title":"Brain Dev."},{"issue":"5","key":"10.1016\/j.parkreldis.2023.105405_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.braindev.2016.11.009","article-title":"A case of severe movement disorder with GNAO1 mutation responsive to topiramate","volume":"39","author":"Sakamoto","year":"2017","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.parkreldis.2023.105405_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mdc3.13383","article-title":"Good response to deep brain stimulation in two forms of inherited chorea related to GNAO1 and neuroacanthocystosis with illustrative videos","volume":"9","author":"Yamamoto","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.parkreldis.2023.105405_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116710","article-title":"Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: a case report","volume":"411","author":"Yamashita","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"14","key":"10.1016\/j.parkreldis.2023.105405_bib36","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1177\/0883073816666474","article-title":"Recurrent GNAO1 mutations associated with developmental delay and a movement disorder","volume":"31","author":"Menke","year":"2016","journal-title":"J. Child Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2023.105405_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0883073815587945","article-title":"Progressive movement disorder in brothers carrying a GNAO1 mutation responsive to deep brain stimulation","volume":"31","author":"Kulkarni","year":"2016","journal-title":"J. Child Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105405_bib38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/hmg\/ddab296","article-title":"Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia","volume":"31","author":"Di Rocco","year":"2022","journal-title":"Hum Mol Genet. Hum Mol Genet."},{"issue":"6","key":"10.1016\/j.parkreldis.2023.105405_bib39","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/mds.29006","article-title":"Efficacy of caffeine in ADCY5-related dyskinesia: a retrospective study","volume":"37","author":"M\u00e9neret","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105405_bib40","article-title":"Restoration of the GTPase activity of G\u03b1o mutants by Zn2+ in GNAO1 encephalopathy models","author":"Larasati","year":"2021","journal-title":"Research Square"},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105405_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brs.2013.09.001","article-title":"Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson's disease","volume":"7","author":"Alam","year":"2014","journal-title":"Brain Stimul."},{"issue":"4","key":"10.1016\/j.parkreldis.2023.105405_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00702-016-1656-9","article-title":"Deep brain stimulation for dystonia: a novel perspective on the value of genetic testing","volume":"124","author":"Jinnah","year":"2017","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.parkreldis.2023.105405_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/dmcn.14063","article-title":"Deep brain stimulation for pediatric dystonia: a meta-analysis with individual participant data","volume":"61","author":"Elkaim","year":"2019","journal-title":"Dev. Med. Child Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:27:41Z","timestamp":1761179261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"alternative-id":["S1353802023001281"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105405","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GNAO1-related movement disorder: An update on phenomenology, clinical course, and response to treatments","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105405"}}